newsfilter
← Latest News
CNBC·

Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s

Structure Therapeutics CEO Ray Stevens talked about the biotech’s path forward and his expectations for the future of the booming GLP-1 space.